Elevation Oncology, Inc. (ELEV)

USD 0.63

(-6.69%)

Annual Income Statements

(In USD)
Breakdown 2023 2022 2021 2020 2019
Revenue - - - - -
Cost of Revenue 39 Thousand 27 Thousand 18 Thousand 15 Thousand -
Gross Profit -39 Thousand -27 Thousand -18 Thousand -15 Thousand -
Operating Expenses 45.44 Million 94.54 Million 32.04 Million 17.27 Million 5.88 Million
Selling, General and Administrative Expenses 14.9 Million 15.83 Million 8.45 Million 1.8 Million 544 Thousand
Research and Development Expenses 25.43 Million 78.71 Million 23.59 Million 15.47 Million 5.33 Million
Other Expenses 5.1 Million -506 Thousand 7000.00 11 Thousand -
Cost and Expenses 45.44 Million 94.54 Million 32.04 Million 17.27 Million 5.88 Million
Operating Income -45.44 Million -94.54 Million -32.04 Million -17.27 Million -5.88 Million
Interest Expense 4.16 Million 479 Thousand - - -
Income Tax Expense 30 Thousand 25 Thousand -218.55 Thousand -191.29 Thousand -8823.00
Earnings before Tax -45.67 Million -95.05 Million -32.03 Million -17.26 Million -5.88 Million
Net Income -45.7 Million -95.08 Million -32.03 Million -17.26 Million -5.88 Million
Earnings Per Share Basic -1.34 -4.09 -1.38 -0.73 -0.25
Earnings Per Share Diluted -1.34 -4.09 -1.38 -0.73 -0.25
Weighted Average Shares Outstanding 34.07 Million 23.26 Million 23.2 Million 23.75 Million 23.75 Million
Weighted Average Shares Outstanding (Diluted) 34.07 Million 23.26 Million 23.2 Million 23.75 Million 23.75 Million
Gross Margin - - - - -
EBIT Margin - - - - -
Profit Margin - - - - -
EBITDA -41.46 Million -94.52 Million -32.02 Million -17.25 Million -5.88 Million
Earnings Before Tax Margin - - - - -

Income Statement Charts